You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma

[Kidney Cancer 6 (2022) 6979 , DOI 10.3233/KCA-210117]

On page 77, The Funding statement should mention grant code R21CA263264 and be as follows:


This research was supported by the UTSW Kidney Cancer SPORE grant P50CA196516 (J.B. and I.P.) and NIH grant R21CA263264 (J.B.). R. Elias receives support from an institutional award from the Burroughs Wellcome Fund.”